Nymox Pharmaceutical Corp (CE) (NYMXF)
USOTC
News
Market Data
Register for streaming realtime charts, analysis tools, and prices.
The current NYMXF market cap is 9.05k. The company's latest EPS is USD -0.0726 and P/E is -2.75.
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 299k | 116k | 5k | 0 | 0 |
| Operating Income | -10.64M | -13.33M | -11.72M | -12.5M | -6.65M |
| Net Income | -10.59M | -13.16M | -11.74M | -12.54M | -6.58M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 8.08M | 5.49M | 4.34M | 1.44M | 1.63M |
| Total Liabilities | 1.07M | 2.04M | 2.2M | 1.95M | 2.11M |
| Total Equity | 7M | 3.45M | 2.15M | -506k | -482k |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -7.8M | -7.43M | -10.04M | -9.82M | -5.21M |
| Investing | -36k | N/A | -13k | -6k | N/A |
| Financing | 14.93M | 4.72M | 8.42M | 7.05M | 5.78M |
| Market Cap | 9.05k |
| Price to Earnings Ratio | -2.75 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 12.9 |
| Price to Book Ratio | -37.56 |
| Dividend Yield | - |
| Shares Outstanding | 90.52M |
| Average Volume (1 week) | 22.5k |
| Average Volume (1 Month) | 15.08k |
| 52 Week Change | -99.99% |
| 52 Week High | 1.40 |
| 52 Week Low | 0.0001 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Nymox Pharmaceutical Corp (CE) |
| Address |
bay & deveaux sts., 2nd floor nassau H4M 2V2 |
| Website | https://www.nymox.com |
| Industry | chemicals & chem preps, nec (2899) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
